AS

Andrew Stephens

Cleo Diagnostics Ltd | Chief Scientific Officer, Executive Director
Dr Stephens is a career research scientist with 20 years experience in molecular and cellular biology research. He has experience in academic and pre-clinical research, and a focus on translation and the commercialisation of research findings. He established and leads an independent academic research group at the Hudson Institute of Medical Research, investigating mechanisms that contribute to the formation, progression and dissemination of high grade, serous epithelial ovarian cancers. Since 2010, his research has focused on biomarker identification and development in ovarian cancer, and the development of therapeutic strategies to improve patient outcomes. He is also actively involved across the biotech sector, with appointments to the scientific advisory for Invion Ltd and AMTBio Pty Ltd.

Company and Roles

Company
Title
Tenure
Since
COV
Cleo Diagnostics Ltd
  • Chief Scientific Officer
  • Executive Director
1yrs, 7mthSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
COV
Cleo Diagnostics Ltd
27/09/23N/A500,0001,500,000N/A